Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERAS Approach for Post-craniotomy Headache
NCT07510217Phase 2Completed
- Sponsor
- Tanta University
- Start
- Aug 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine, bupivacaine hydrochloride 0.75% injection in Post-craniotomy headache (PCH), sponsored by Tanta University. Started Aug 2024; status: completed.
02
Drugs
dexmedetomidinebupivacaine hydrochloride 0.75% injection
03
Conditions
Post-craniotomy headache (PCH)
Beyond the preview
Go deeper on NCT07510217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07510217.